Form 4 for HTFL Heartflow, Inc.

Accepted 2026-05-20 17:55:39 ET · period of report 2026-05-18 · accession 0001464521-26-000073 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DT	2026-05-20 17:55	2026-05-18	HTFL	Rogers Campbell	Chief Medical Off	M - OptEx	$19.00	+9,219	88.0K	+12%	+$175.2K
DT	2026-05-20 17:55	2026-05-18	HTFL	Rogers Campbell	Chief Medical Off	S - Sale+OE	$28.34	-9,219	78.7K	-10%	-$261.3K
DT	2026-05-20 17:55	2026-05-18	HTFL	Rogers Campbell	Chief Medical Off	M - OptEx	$0.00	-9,219	101.4K	-8%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-05-18	M	A	9,219	$19.00	87,950	D	—	—	(F1) The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025.
2	Common	Common Stock	2026-05-18	S	D	9,219	$28.34	78,731	D	—	—	(F1) The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025.
3	Derivative	Stock Options	2026-05-18	M	D	9,219	$0.00	101,410	D	$19.00 · — to 2035-08-07	9,219 Common Stock	(F1) The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025. (F2) The option vests and becomes exercisable in monthly installments until August 7, 2029, subject to continued service through the applicable vesting date.